JMP Securities Increases HealthEquity (NASDAQ:HQY) Price Target to $117.00

HealthEquity (NASDAQ:HQY) had its price objective increased by JMP Securities from $110.00 to $117.00 in a report issued on Wednesday morning, MarketBeat reports. The brokerage currently has a market outperform rating on the stock.

A number of other research firms have also recently commented on HQY. The Goldman Sachs Group decreased their price target on HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a research note on Thursday, March 27th. Raymond James upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and cut their price objective for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. Bank of America raised their target price on HealthEquity from $110.00 to $125.00 and gave the company a “buy” rating in a report on Wednesday. Barrington Research reaffirmed an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a research report on Friday, April 11th. Finally, KeyCorp cut their price target on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 16th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, HealthEquity presently has an average rating of “Buy” and an average target price of $118.09.

HealthEquity Stock Down 1.0%

Shares of NASDAQ:HQY opened at $111.55 on Wednesday. The company has a market capitalization of $9.65 billion, a price-to-earnings ratio of 102.34, a PEG ratio of 1.60 and a beta of 0.45. HealthEquity has a 12-month low of $65.01 and a 12-month high of $116.65. The business has a 50-day moving average price of $91.48 and a 200 day moving average price of $97.80. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.16. The company had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter last year, the firm posted $0.80 earnings per share. Sell-side analysts expect that HealthEquity will post 2.32 EPS for the current year.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now directly owns 84,969 shares of the company’s stock, valued at approximately $6,597,842.85. The trade was a 6.34% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the business’s stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. The trade was a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

Hedge Funds Weigh In On HealthEquity

Large investors have recently modified their holdings of the stock. Pier Capital LLC bought a new stake in HealthEquity during the fourth quarter valued at $8,024,000. HighTower Advisors LLC grew its position in shares of HealthEquity by 4.8% during the 4th quarter. HighTower Advisors LLC now owns 95,075 shares of the company’s stock valued at $9,122,000 after buying an additional 4,370 shares during the last quarter. Wells Fargo & Company MN grew its position in shares of HealthEquity by 4.7% during the 4th quarter. Wells Fargo & Company MN now owns 124,940 shares of the company’s stock valued at $11,988,000 after buying an additional 5,594 shares during the last quarter. Geneva Capital Management LLC raised its stake in HealthEquity by 24.6% during the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock worth $100,642,000 after acquiring an additional 206,894 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in HealthEquity by 2.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company’s stock worth $104,280,000 after acquiring an additional 25,004 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.